;
Skip to main content
Home > Week in Review > Offerings

Chronological Index of : Financial News

 Current Issue
  • Coherus BioSciences proposes IPO

    Coherus BioSciences Inc., Redwood City, Calif. Business: Biosimilars Date announced: 2014-09-25 Type: IPO To be raised: Up to $86.3 million Shares: TBD Price: TBD Underwriters: JPMorgan; Credit Suisse; Cowen Note: The …

    Published on 9/29/2014
  • DBV proposes follow-on

    DBV Technologies (Euronext:DBV), Bagneux, France Business: Inflammation, Diagnostic Date announced: 2014-09-22 Type: Follow-on To be raised: Up to $69.1 million Shares: 3 million Price prior: EUR25.42 Underwriters: …

    Published on 9/29/2014
  • HedgePath Pharmaceuticals proposes private placement

    HedgePath Pharmaceuticals Inc. (Pink:HPPI), Tampa, Fla. Business: Cancer Date announced: 2014-09-17 Type: Private placement To be raised: Up to $5 million Shares: TBD Price prior: $0.15 Shares outstanding prior: 211.4 …

    Published on 9/29/2014
  • Molecular Partners proposes IPO

    Molecular Partners AG, Schlieren, Switzerland Business: Ophthalmic, Cancer, Inflammation Date announced: 2014-09-23 Type: IPO To be raised: CHF125 million ($133.1 million) Shares: TBD Price: TBD Underwriters: JPMorgan; …

    Published on 9/29/2014
  • Probiodrug proposes IPO

    Probiodrug AG, Halle/Saale, Germany Business: Neurology, Autoimmune, Inflammation Date announced: 2014-09-25 Type: IPO To be raised: TBD Shares: TBD Price: TBD Underwriters: Kempen & Co.; Petercam; Close Brothers Note: …

    Published on 9/29/2014
  • Vital Therapies proposes follow-on

    Vital Therapies Inc. (NASDAQ:VTL), San Diego, Calif. Business: Hepatic Date announced: 2014-09-19 Type: Follow-on To be raised: Up to $46 million Shares: TBD Price prior: $20.11 Underwriters: BofA Merrill Lynch; William…

    Published on 9/29/2014
  • Calithera Biosciences amends IPO

    Calithera Biosciences Inc., South San Francisco, Calif. Business: Cancer Date announced: 2014-09-19 Type: IPO To be raised: Up to $90 million Shares: 6 million Price: $13-$15 Underwriters: Citigroup; Leerink Partners; …

    Published on 9/22/2014
  • Civitas amends IPO

    Civitas Therapeutics Inc., Chelsea, Mass. Business: Drug delivery, Neurology, Pulmonary Date announced: 2014-09-15 Type: IPO To be raised: Up to $80 million Shares: 5 million Price: $14-$16 Underwriters: JPMorgan; …

    Published on 9/22/2014
  • Dermira amends IPO

    Dermira Inc., Redwood City, Calif. Business: Dermatology Date announced: 2014-09-19 Type: IPO To be raised: Up to $85.6 million Shares: 5.4 million Price: $14-$16 Underwriters: Citigroup; Leerink Partners; Guggenheim …

    Published on 9/22/2014
  • EyeGate amends IPO

    EyeGate Pharmaceuticals Inc., Waltham, Mass. Business: Ophthalmic Date announced: 2014-09-12 Type: IPO To be raised: Up to $26.9 million Shares: 1.9 million Price: $12-$14 Underwriter: Aegis Capital Overallotment: 288,…

    Published on 9/22/2014
  • AbGenomics completes venture financing

    AbGenomics International Inc., Los Altos, Calif. Business: Antibodies Date completed: 2014-08-27 Type: Venture financing Raised: $13.2 million Note: The company raised $13.2 million, according to an SEC filing.

    Published on 9/22/2014
  • Airway Therapeutics completes venture financing

    Airway Therapeutics LLC, Cincinnati, Ohio Business: Pulmonary Date completed: 2014-09-10 Type: Venture financing Raised: $4.6 million Investors: CincyTech; Cincinnati Children's Hospital Medical Center; Queen City …

    Published on 9/22/2014
  • Aratana completes follow-on

    Aratana Therapeutics Inc. (NASDAQ:PETX), Kansas City, Kan. Business: Veterinary Date completed: 2014-09-17 Type: Follow-on Raised: $47.9 million Shares: 5.2 million Price: $9.25 Shares after offering: 34.6 million …

    Published on 9/22/2014
  • Avraham Pharmaceuticals completes venture financing

    Avraham Pharmaceuticals Ltd., Yavneh, Israel Business: Neurology Date completed: 2014-09-17 Type: Venture financing Raised: $4.5 million Investors: Yissum Ltd.; Pontifax; Clal Biotechnology Industries; Technion Research…

    Published on 9/22/2014
  • Cardiorentis completes venture financing

    Cardiorentis AG, Zug, Switzerland Business: Cardiovascular Date completed: 2014-09-17 Type: Venture financing Raised: EUR45 million ($58.2 million) Investor: Healthcare Royalty Partners

    Published on 9/22/2014
  • Foamix completes IPO

    Foamix Ltd. (NASDAQ:FOMX), Ness Ziona, Israel Business: Drug delivery Date completed: 2014-09-18 Type: IPO Raised: $40.2 million Shares: 6.7 million Price: $6 Shares after offering: 21.5 million Underwriters: Barclays …

    Published on 9/22/2014
  • Genisphere completes venture financing

    Genisphere LLC, Hatfield, Pa. Business: Supply/Service Date completed: 2014-09-16 Type: Venture financing Raised: $2 million Investors: Corporate Fuel Partners; existing investors

    Published on 9/22/2014
  • Medifocus completes private placement of units

    Medifocus Inc. (TSX-V:MFS; OTCQX:MDFZF), Vancouver, B.C. Business: Cancer Date completed: 2014-09-15 Type: Private placement of units Raised: $1.6 million Units: 10.3 million Price: $0.16 (unit) Shares after offering: …

    Published on 9/22/2014
  • MGB Biopharma completes venture financing

    MGB Biopharma Ltd., Glasgow, U.K. Business: Infectious Date completed: 2014-09-17 Type: Venture financing Raised: L2.7 million ($4.4 million) Investors: Archangel Informal Investment; Barwell plc; Tri Capital Ltd.; …

    Published on 9/22/2014
  • Nordic Nanovector completes venture financing

    Nordic Nanovector A/S, Oslo, Norway Business: Cancer Date completed: 2014-09-16 Type: Venture financing Raised: NOK50 million ($7.8 million) Investor: Existing investors Note: The company raised NOK50 million ($7.8 …

    Published on 9/22/2014
  • Oncothyreon completes follow-on

    Oncothyreon Inc. (NASDAQ:ONTY), Seattle, Wash. Business: Cancer Date completed: 2014-09-18 Type: Follow-on Raised: $20 million Shares: 10 million Price: $2 Shares after offering: 80.8 million Underwriters: Cowen; H.C. …

    Published on 9/22/2014
  • Oncothyreon completes private placement of convertible preferred stock

    Oncothyreon Inc. (NASDAQ:ONTY), Seattle, Wash. Business: Cancer Date completed: 2014-09-18 Type: Private placement of convertible preferred stock Raised: $20 million Shares: 10,000 Price: $2,000 Shares outstanding prior…

    Published on 9/22/2014
  • PhosImmune completes venture financing

    PhosImmune Inc., Charlottesville, Va. Business: Cancer Date completed: 2014-09-12 Type: Venture financing Raised: $125,000 Investor: Center for Innovative Technology (CIT) GAP Fund Note: The company raised $125,000 in …

    Published on 9/22/2014
  • Poxel completes venture financing

    Poxel S.A., Lyon, France Business: Endocrine/Metabolic Date completed: 2014-09-09 Type: Venture financing Raised: EUR5 million ($6.5 million) Investor: Kreos Capital Note: The company declined to disclose terms of the …

    Published on 9/22/2014
  • ProQR Therapeutics completes IPO

    ProQR Therapeutics N.V. (NASDAQ:PRQR), Leiden, the Netherlands Business: Pulmonary Date completed: 2014-09-18 Type: IPO Raised: $97.5 million Shares: 7.5 million Price: $13 Shares after offering: 22.2 million …

    Published on 9/22/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993